8-KLeadership ChangesExhibits & Filings

EXPEDITORS INTERNATIONAL OF WASHINGTON INC 8-K Report, Executive Changes (Sep 30, 2008)

Filed September 30, 2008For Securities:EXPD

Summary

This Form 8-K filing from Expeditors International of Washington, Inc. (EXPD) on September 30, 2008, primarily announces a significant change in executive leadership. The company has appointed Bradley S. Powell as its new Chief Financial Officer (CFO), effective October 1, 2008. Mr. Powell brings extensive financial experience, having previously served as CFO, President, and Secretary of Eden BioScience Corporation since 1998. Investors should note the compensation package for the new CFO, which includes a base salary of $100,000 annually, eligibility for the Executive Bonus Pool, and a stock option grant of 5,000 shares. This leadership transition is a key event for the company, and Mr. Powell's financial acumen will be crucial in navigating the current economic climate. The filing also includes the press release detailing this appointment as an exhibit.

Key Highlights

  • 1Bradley S. Powell appointed as Chief Financial Officer (CFO) effective October 1, 2008.
  • 2Mr. Powell has significant prior experience as CFO, President, and Secretary of Eden BioScience Corporation since 1998.
  • 3New CFO's annual base salary set at $100,000.
  • 4Mr. Powell will be eligible for the Company's Executive Bonus Pool under the 2008 Executive Incentive Compensation Plan.
  • 5A stock option grant of 5,000 shares from the 2008 Stock Option Plan will be awarded to Mr. Powell.
  • 6The press release announcing the appointment is filed as Exhibit 99.1.

Frequently Asked Questions

Bradley S. Powell has been appointed as the new CFO, with his tenure officially beginning on October 1, 2008.

Mr. Powell will receive an annual base salary of $100,000. He is also eligible for the Company's Executive Bonus Pool and will be granted an option to purchase 5,000 shares of company stock.

Mr. Powell has extensive financial leadership experience, having served as Chief Financial Officer of Eden BioScience Corporation since July 1998, and also held roles as President and Secretary at the same company.

The filing also includes a press release dated September 29, 2008, announcing the appointment of Mr. Powell, which is attached as Exhibit 99.1.